Some University of Arkansas for Medical Sciences employees saw red flags long before auditors discovered a deficit at the Myeloma Institute for Research & Therapy that was allowed to grow to $29 million over nine years. read more >
When the University of Arkansas for Medical Sciences announced in April 2014 that Dr. Gareth Morgan would lead the Myeloma Institute for Research & Therapy, it was cause for a celebration. The cheers didn’t last long. read more >
The audit of the Myeloma Institute should be able to determine if there’s any money unaccounted for in the cancer program. The accounting is expected to be final after January. read more >
Steve Stephens, 88, sat down over Starbucks coffee this month in the Heights, recounting some 65 years in Arkansas media and recalling the dance party program that made him famous, “Steve’s Show.” read more >
Natalie Rockefeller has been named to the board of directors of the Winthrop P. Rockefeller Cancer Institute Foundation. read more >
Dr. Jill M. Mhyre has been appointed chair of the Department of Anesthesiology in the College of Medicine at the University of Arkansas for Medical Sciences in Little Rock. read more >
The University of Arkansas for Medical Sciences is looking for a few good administrators. read more >
Dr. John Brizzolara and Dr. Teryn Driver have joined the Saline Memorial Hospital team. read more >
Pebbles Fagan has been named the director of the Center for the Study of Tobacco at the Fay W. Boozman College of Public Health at the University of Arkansas for Medical Sciences. read more >
A Springdale company is raising $5 million to move forward with its plans to sell breast cancer screening tests. read more >
The Affordable Care Act as applied in Arkansas has worked so well for the University of Arkansas for Medical Sciences that administrators are considering expanding the 10-story UAMS Medical Center. read more >
The University of Arkansas for Medical Sciences had an operating loss of $27.8 million in the first six months of its current fiscal year, a dramatic downturn from an $8.5 million operating gain during the same period a year earlier. read more >
